We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Advisory Committee Supports Agile Therapeutics’ Birth Control Patch
Advisory Committee Supports Agile Therapeutics’ Birth Control Patch
An FDA advisory committee voted 14 to two on Wednesday to recommend FDA approval of Agile Therapeutics’ birth control patch AG 200-15 (levonorgestrel/ethinyl estradiol).